NEOGLIP XR 50+500MG TAB

NEOGLIP XR 50+500MG combines sitagliptin and metformin HCl in an extended-release formulation designed to help manage type 2 diabetes. This dual-action tablet works by enhancing insulin secretion and improving glucose control throughout the day. The extended-release mechanism ensures consistent medication delivery, supporting better blood sugar management with convenient once or twice-daily dosing. Ideal for patients requiring combination therapy to achieve optimal glycemic control.